Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 3286 to 3300 of 7683 results

  1. Life sciences: how to get your product to market

    Support for industry to engage with NICE during all stages of health technology development

  2. Commercial Liaison Team

    The Commercial Liaison Team (CLT) works with companies who are considering a patient access scheme for their drug or treatment. Patient access schemes

  3. What we do

    Role and responsibilities of the National Institute of Health and Care Excellence

  4. Artificial intelligence (AI) and digital regulations service

    NICE's leading role in designing a new service to support the development and adoption of AI and data-driven technologies in health and care.

  5. Privacy notice

    How we collect and use your personal information, and your rights under data protection legislation

  6. Interventional procedures advisory committee

    Advises NICE on the formulation of its guidance on the safety and efficacy of interventional procedures.

  7. Freedom of information publication scheme

    Our publication scheme lists all of the information we routinely make available, and where you can find it. We publish most of the information below...

  8. Transparency of spend

    NICE transparency of spend

  9. Highly specialised technologies evaluation committee members

    Highly specialised technologies evaluation committee members

  10. Our programmes

    The different types of health, public health and social care information provided by NICE.

  11. Appeal panel membership

    The appeal panel is drawn from a group of people approved by the Secretary of State for Health and Social Care to hear appeals. Read the appeal panel

  12. Managed access

    Managed access allows patients to access promising new treatments that would otherwise not be recommended because it is too uncertain whether the treatment is cost-effective.

  13. NICE real-world evidence framework (ECD9)

    The NICE real-world evidence framework aims to improve the quality of real-world evidence informing our guidance. The framework does not set minimum standards for the acceptability of evidence. The framework is mainly targeted at those developing evidence to inform NICE guidance. It is also relevant to patients, those collecting data, and reviewers of evidence

  14. Indicator advisory committee (IAC)

    We work with an independent indicator advisory committee (IAC) to develop indicators suitable for inclusion in the Quality and Outcomes Framework...

  15. Intrabeam radiotherapy system for adjuvant treatment of early breast cancer . Patient decision aid on intrabeam radiotherapy for treating early breast cancer

    Decision aid for Intrabeam radiotherapy system for adjuvant treatment of early breast cancer, TA501 c NICE 2018. All rights reserved. Subject to...